To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open3,722
High3,755
Low3,687.5
Prev. Close3,741.9
Avg. Traded Price3,721.62
Volume2,61,716

MARKET DEPTH

info2
Total bid92.00
Total ask0.00
OrdersQtyBid
2923741.9
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

3,687.5018 hours ago
3,755.0013 hours ago
arrow

LOWER/UPPER CIRCUITS

3,357.60
4,103.60
arrow
Torrent Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 6.99%, in the last year to ₹11,539.36 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 15.39% in the last year to ₹1,911.25 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
noteReturn on Equity(ROE),for the last financial year was 25.17%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 21.68%
Net profit growth 5Y CAGR : 30.59%

STOCK RETURNS

info
Versus Nifty 50
1 w
+3.41%
vs
-1.52%
1 mth
+6.30%
vs
-3.28%
3 mth
+9.03%
vs
+1.42%
6 mth
+7.81%
vs
+6.55%
1 yr
+13.27%
vs
-0.62%
3 yr
+136.98%
vs
+43.84%
5 yr
+204.06%
vs
+120.31%
Torrent Pharmaceuticals Ltd Top mutual funds holding
arrow
Torrent Pharmaceuticals Limited has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
personal

Grow your wealth with more research recommendations

+91